lec7 pharmacodynamics Flashcards

1
Q

categories of drug effects

A

therapeutic
nontherapeutic
placebo

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

dose intensity curves measures

A

how much effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

dose frequency curves measures

A

hoe many affected

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

application of the law of mass action to the kinetics of the binding of drug and receptor creates the equation

A

drug + receptor bound-receptor –> effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

dissociation constant (Kd) for the drug from the receptor is measured by (2 equations for it)

A

=Kr/Kf
K reverse / K forward
or
= drug + receptor / bound-receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

the curve for durg conc v fraction of bound receptors (i.e. bound / total receptors) is what shape

A

hyperbolic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

the conc at which half of the receptors are bound is the

A

Kd = dissociation constant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Bmax is the

A

totality of the receptors bound by the drug

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

why are semilogarithmic plots used instead of linear (hyperbola)

A

linear plots at point near zero, the effect changes rapidly
semi log curve has large middle portion close to EC50 which is linear and easier to work with so easier to make accurate determination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Emax =

A

maximum effect

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

what is used as a measure of Kd

A

EC50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

lower EC50 means what to the affinity for binding to the receptor

A

lower EC50 –> lower Kd –> higher affinity for binding to the receptor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

drug conc producing an effect that’s 50% of the max effect

A

EC50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

EC50 provides what important characteristic of drugs

A

potency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Emax provides what important characteristic of drugs

A

efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

define efficacy

A

max effect of a drug achieveable at a high dose

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

lower EC50 = ____ potency

A

higher

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

lower Emax = ____ efficacy

A

lower

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

when comparing 2 drugs you want the one with the lower or higher Emax

A

higher

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

how well the drug binds the receptor

A

potency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

how well the drug produces the effect

A

efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

t/f potency and efficacy are related

A

f: unrelated

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

potency is ___ related to EC50

A

inversely

lower potency = higher EC50

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

ability of a drug to affect one tissue or receptor in prefereance to another

A

selectivity

25
a highly selective drug is one which
affects only a receptor or tissue without affecting others
26
what curve is needed to measure selectivity
concentration - response
27
what type of agonist: drug that has efficacy greater than zero but less than a full agonist
partial agonist
28
what type of agonist: drug that binds to a receptor and produces max bio response
full agonist
29
what type of agonist: drug that induces pharm response opposite of agonist
inverse agonist
30
what is a neutral antagonist
drug that does NOT induce a bio response and reduces/blocks response induced by agonist
31
order the 3 agonists from highest emax to lowest
full > partial > inverse
32
process where a drug decr or opposes action of another drug or endogenous ligand
antagonism
33
what are the 4 types of antagonisms
chemical pharmacokinetic physiological pharmacological
34
type of antagonism where antagonist accelerates the metabolism or the elimination of the agonist
pharmacokinetic
35
type of antagonism where antagonist binds directly to agonistto make it inactive
chemical
36
type of antagonism where theres 3 types | reversible competitive, noncompetitive, irreversible
pharmacological
37
type of antagonismwhere antagonist activates a diff mechanism that opposes the effects of the agonist
physiological
38
what happens to potency and efficacy in reversible competitive
right shift of dose-response curve higher EC50 --> lower potency no change in efficacy
39
competitive antagonism can be overcome by
incr the conc of agonist to achieve the same effect as before
40
can a noncompetitive antagonism be overcome
no cant restory to original response by incr conc of agonist
41
what happens to potency and efficacy in noncompetitive
lower emax --> decr efficacy | unchanged potency
42
what happens to potency and efficacy in irreversible competitive
lower emax --> decr effcacy | no change potency
43
joint effect of 2 drugs is the sum of their individual effects
summation
44
joint effect of 2 drugs is greater than sum of their effects
synergism
45
inert drug enhances the effect of another drug
potentiation
46
drug effect loss over time
tolerance
47
mechanism for decreased effect (includes tachyphylaxis)
desensitization
48
what curve is all or nothing i.e. their effect is scored on whether present or absent
quantal dose-response curves
49
diff bn incremental and cumulative quantal curves
incremental - as dose incr, number responders incr (bell curve) cumulative - as dose incr, number responders adds up
50
which curve has more variability? shallow, wider taller, narrow
shallow, wide
51
dose producing effect in 50% of subject
ED50
52
dose making death in 50% of subjects
LD 50 = lethal dose
53
what do different slopes in quantal curves imply
diff sources of variability, suggesting diff in route or mechanism of action
54
therapeutic index equation
LD50 / ED50
55
the higher the therapeutic index
the safer the drug
56
why is pop variability important in quantal curves
bc can have same therapeutic index but different risk
57
standardized safety margin equation
(LD1-ED99) / ED99 * 100
58
the more positive the ED99 or the greater the diff bn LD1 and ED99 , the ___ the drug
safer